NCT06698003 2026-03-05
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Memorial Sloan Kettering Cancer Center
Indiana University
Children's Hospital of Philadelphia
French Innovative Leukemia Organisation
Essen Biotech
University of Milano Bicocca